Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: December 2012

Acquity Group Ltd. (AQ) Announces Launch of New TireBuyer.com Site

Posted on December 11, 2012 by MissionIR

Acquity Group, a leading global Brand eCommerce(TM) and digital marketing company, today announced that TireBuyer.com, a subsidiary of American Tire Distributors and one of the nation’s largest replacement tire distributors, has been completely revamped and successfully launched. The revamped site … Continue reading →

Posted in Small Cap News | Leave a comment

Edgewater Technology, Inc. (EDGW) Ranked Among Top 10 Massachusetts Women-Led Businesses

Posted on December 11, 2012 by MissionIR

Leading consulting firm Edgewater Technology announced that the Commonwealth Institute and Boston Business Journal have recognized it as one of the top women-led businesses in the state of Massachusetts. The two nominating bodies hosted the third annual Top 100 Women-Led … Continue reading →

Posted in Small Cap News | Leave a comment

Trius Therapeutics, Inc. (TSRX) Completes Patient Enrollment in Second Phase III of Tedizolid

Posted on December 10, 2012 by MissionIR

Trius Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative antibiotics for life-threatening infections. The company’s lead investigational drug is tedizolid phosphate (TR-701), a once daily, IV and orally-administered second generation oxazolidinone in Phase 3 … Continue reading →

Posted in Small Cap News | Leave a comment

Timberline Resources Corp. (TLR) on Target for Mid-2013 Gold Production near Butte, Montana

Posted on December 10, 2012 by MissionIR

Timberline Resources, the domestic precious mineral developer focused on a portfolio of properties in Idaho, Montana, and Nevada, which holds a 50% carried interest ownership stake in the highly prospective Butte Highlands Gold Project in Montana, reported today that the … Continue reading →

Posted in Small Cap News | Leave a comment

The Long Term Strategy for VistaGen Therapeutics (VSTA)

Posted on December 10, 2012 by MissionIR

VistaGen Therapeutics is focused primarily on the use of its proprietary pluripotent stem cell technology to discover, rescue, and develop novel drug candidates for a wide range of diseases. The idea is to generate new chemical variants of once-promising small … Continue reading →

Posted in VistaGen Therapeutics Inc. VSTA | Leave a comment

Life Partners Holdings, Inc. (LPHI) Video Chart for Monday, December 10, 2012

Posted on December 10, 2012 by MissionIR

LPHI is back on the climb after a consolidation period following a huge move in late September. The consolidation has been marked by a double bottom type pattern with slightly higher lows and highs. A breakout through the top happened … Continue reading →

Posted in Technical Analysis | Leave a comment

Bioanalytical Systems, Inc. (BASI) to Collaborate with DSI on Groundbreaking New Study

Posted on December 10, 2012 by MissionIR

Friday, Bioanalytical Systems announced a collaboration with Data Sciences International (DSI) to conduct a pioneering study that combines Bioanalytical Systems’ Culex-L automated sampling system with PhysioTel Digital, DSI’s latest large animal telemetry technology. DSI is a biomedical research company with … Continue reading →

Posted in Small Cap News | Leave a comment

TG Therapeutics, Inc. (TGTX) Initiates Clinical Trial to Evaluate TG-1101, Lenalidomide Combination

Posted on December 7, 2012 by MissionIR

Clinical-stage biopharm company TG Therapeutics today announced that it has initiated a phase I/II trial to evaluate the safety, tolerability, and efficacy of TG-1101, the company’s novel third-generation anti-CD20 monoclonal antibody, in combination with lenalidomide (Revlimid®) for patients with relapsed … Continue reading →

Posted in Small Cap News | Leave a comment

LifeTech Capital Provides Coverage Update on FluoroPharma Medical, Inc. (FPMI)

Posted on December 7, 2012 by MissionIR

Earlier this week, LifeTech Capital issued an update on its FluoroPharma Medical coverage. The latest report reiterates the stock as a “Strong Speculative Buy” and sets a $2.50 price target. The entire 23-page report can be viewed at the following … Continue reading →

Posted in FluoroPharma Medical Inc. FPMI | Leave a comment

Xplore Technologies Corp. (XPLR) Lands Multi-Million Dollar Purchase Order for Ruggedized Tablet PCs

Posted on December 7, 2012 by MissionIR

Xplore Technologies, developers of the world’s most ruggedly designed tablet PCs, known throughout sectors like military and oil/gas production for their award-winning computing platforms that are engineered from the ground up to withstand the most difficult and challenging environments possible, … Continue reading →

Posted in Small Cap News | Leave a comment